Certified by Founder Lodge
Parse Biosciences
United States - Seattle, WA
START UP
1 Disclosed Funding Rounds $41,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. With technology founded on the principles of SPLiT-se
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 15 ,2022 | Series B | $41,500,000 | |
| December, 18 ,2023 | Series C | $50,000,000.00 |
Marshall Wace
Janus Henderson Investors
Bioeconomy Capital
Soleus Capital Management, L.P.
Logos Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
